emtricitabine
SpainDrugs containing this active substance
-
It is used for the treatment of human immunodeficiency virus type 1 (HIV-1) infection in adults. It helps reduce the amount of virus in the body, which improves the immune system.
Form: tablets, film-coated
Active substance Dosage bictegravir sodium 52,45 mg emtricitabine 200 mg tenofovir alafenamide fumarate 28,04 mg Manufacturer: Gilead Sciences Ireland Unlimited Company
-
It is used in combination with other medications for the treatment of human immunodeficiency virus-1 (HIV-1) infection in adults and adolescents 12 years of age and older who weigh at least 35 kg.
Form: tablets, film-coated
Active substance Dosage emtricitabine 200 mg tenofovir alafenamide 10 mg Manufacturer: Gilead Sciences Ireland Unlimited Company
-
It is used in combination with other medicines for the treatment of human immunodeficiency virus 1 (HIV-1) infection in adults and adolescents aged 12 years or older who weigh at least 35 kg.
Form: tablets, film-coated
Active substance Dosage emtricitabine 200 mg tenofovir alafenamide 25 mg Manufacturer: Gilead Sciences Ireland Unlimited Company
-
It is used to treat human immunodeficiency virus (HIV) infection in adults aged 18 years or older who have previously received other antiretroviral treatments and have had their infection under control for at least three months.
Form: tablets, film-coated
Active substance Dosage efavirenz 600 mg emtricitabine 200 mg tenofovir disoproxil fumarate 300 mg Manufacturer: Aurovitas Spain, S.A.U.
-
Efavirenz/Emtricitabine/Tenofovir disoproxil Glenmark is used to treat human immunodeficiency virus (HIV) infection in adults aged 18 years or older who have already received other antiretroviral treatments and have had the infection under control for at least three months.
Form: tablets, film-coated
Active substance Dosage efavirenz 600 mg emtricitabine 200 mg tenofovir disoproxil fumarate 300 mg Manufacturer: Glenmark Arzneimittel Gmbh
-
It is used to treat human immunodeficiency virus (HIV) infection in adults aged 18 years or older who have previously received other antiretroviral treatments and have had their infection under control for at least three months.
Form: tablets, film-coated
Active substance Dosage efavirenz 600 mg emtricitabine 200 mg tenofovir disoproxil fumarate 300 mg Manufacturer: Macleods Pharma Espana S.L.U.
-
Efavirenz/Emtricitabine/Tenofovir disoproxil Teva is used to treat human immunodeficiency virus (HIV) infection in adults aged 18 years or older who have already received other antiretroviral treatments and have had the infection under control for at least three months.
Form: tablets, film-coated
Active substance Dosage efavirenz 600 mg emtricitabine 200 mg tenofovir disoproxil fumarate 291,22 mg Manufacturer: Teva Pharma S.L.U.
-
It is used to treat human immunodeficiency virus type 1 (HIV-1) infection in adults and adolescents aged 12 to 18 years weighing at least 35 kg who have already received other treatments. It is also used to reduce the risk of contracting HIV in adults and adolescents aged 12 to 18 years (weighing at least 35 kg) when used daily alongside safer sexual practices.
Form: tablets, film-coated
Active substance Dosage emtricitabine 200 mg tenofovir disoproxil fumarate 300 mg Manufacturer: Aurovitas Spain, S.A.U.
-
It is used to treat infection with Human Immunodeficiency Virus type 1 (HIV-1) in adults and adolescents aged 12 to under 18 years who weigh at least 35 kg. It is also used to reduce the risk of acquiring HIV-1 infection in adults and adolescents aged 12 to 18 years weighing at least 35 kg, provided it is taken daily along with safer sexual practices.
Form: tablets, film-coated
Active substance Dosage emtricitabine 200 mg tenofovir disoproxil fumarate 291 mg Manufacturer: Glenmark Arzneimittel Gmbh
-
It is used to treat Human Immunodeficiency Virus type 1 (HIV-1) infection in adults and adolescents aged 12 to less than 18 years who weigh at least 35 kg. It is also used to reduce the risk of contracting HIV in adults and adolescents aged 12 to less than 18 years (with a minimum weight of 35 kg) when taken daily along with safer sexual practices.
Form: tablets, film-coated
Active substance Dosage emtricitabine 200 mg tenofovir disoproxil fumarate 300 mg Manufacturer: Macleods Pharma Espana S.L.U.
-
It is used to treat Human Immunodeficiency Virus type 1 (HIV-1) infection in adults and adolescents aged 12 to less than 18 years weighing at least 35 kg. It is also used to reduce the risk of acquiring HIV-1 infection in adults and adolescents aged 12 to less than 18 years (weighing at least 35 kg) when used daily alongside safer sexual practices.
Form: tablets, film-coated
Active substance Dosage emtricitabine 200 mg tenofovir disoproxil fumarate 300 mg Manufacturer: Mylan Pharmaceuticals Limited
-
It is used to treat Human Immunodeficiency Virus type 1 (HIV-1) infection in adults and adolescents aged 12 to less than 18 years weighing at least 35 kg. It is also used to reduce the risk of contracting HIV in adults and adolescents aged 12 to less than 18 years (weighing at least 35 kg) when used daily alongside safer sexual practices.
Form: tablets, film-coated
Active substance Dosage emtricitabine 200 mg tenofovir disoproxil fumarate 291,22 mg Manufacturer: Teva Pharma S.L.U.
-
It is used to treat human immunodeficiency virus (HIV) infection in adults, children, and infants 4 months of age or older. It must always be used in combination with other drugs.
Form: solution, oral
Active substance Dosage emtricitabine 10 mg Manufacturer: Gilead Sciences Ireland Unlimited Company
-
It is used to treat human immunodeficiency virus (HIV) infection in adults, children, and adolescents up to 18 years of age weighing at least 33 kg, as well as in infants 4 months of age or older.
Form: capsules, hard
Active substance Dosage emtricitabine 200 mg Manufacturer: Gilead Sciences Ireland Unlimited Company
-
It is used to treat Human Immunodeficiency Virus (HIV) infection in adults aged 18 years or older. It helps reduce the amount of virus in the body, which improves the immune system.
Form: tablets, film-coated
Active substance Dosage emtricitabine 200 mg rilpivirine 27,5 mg tenofovir disoproxil fumarate 300 mg Manufacturer: Gilead Sciences Ireland Unlimited Company
-
It is used for the treatment of human immunodeficiency virus (HIV-1) infection in adults, adolescents, and children aged 6 years or older weighing at least 25 kg. It helps reduce the amount of virus in the body to improve the immune system.
Form: tablets, film-coated
Active substance Dosage emtricitabine 200 mg tenofovir alafenamide 10 mg elvitegravir 150 mg cobicistat 150 mg Manufacturer: Gilead Sciences Ireland Unlimited Company
-
It is an antiviral medication used to treat infection caused by the human immunodeficiency virus (HIV). It helps reduce the amount of virus in the body, which improves the immune system.
Form: tablets, film-coated
Active substance Dosage emtricitabine 200 mg rilpivirine 25 mg tenofovir alafenamide 25 mg Manufacturer: Gilead Sciences Ireland Unlimited Company
-
It is used to treat human immunodeficiency virus (HIV) infection in adults and adolescents aged 12 to 18 years who weigh at least 35 kg and who have previously received other HIV treatments that caused side effects.
Form: tablets, film-coated
Active substance Dosage cobicistat 150 mg emtricitabine 200 mg tenofovir disoproxil fumarate 245 mg elvitegravir 150 mg Manufacturer: Gilead Sciences Ireland Unlimited Company
-
It is used to treat human immunodeficiency virus type 1 (HIV-1) infection in adults and adolescents aged 12 years or older who weigh at least 40 kg. It helps reduce the amount of virus in the body and improves the immune system, although it is not a cure.
Form: tablets
Active substance Dosage darunavir ethanolate 867 mg cobicistat 150 mg emtricitabine 200 mg tenofovir alafenamide fumarate 11,2 mg Manufacturer: Janssen-Cilag International N.V
-
It is used to treat infection with Human Immunodeficiency Virus type 1 (HIV-1) in adults and adolescents aged 12 to less than 18 years weighing at least 35 kg. It is also used to reduce the risk of acquiring HIV-1 in adults and adolescents aged 12 to less than 18 years (weighing at least 35 kg) when taken daily along with safer sexual practices.
Form: tablets, film-coated
Active substance Dosage tenofovir 245 mg emtricitabine 200 mg Manufacturer: Gilead Sciences Ireland Unlimited Company